Intervention group | |||||||
---|---|---|---|---|---|---|---|
Characteristics | Control group (n = 7) | p value | Intake frequency of <50% ile (n = 12) | p value | Intake frequency of ≥50% ile (n = 16) | p value | |
Baseline | 185 ± 32 | 222 ± 26 | 211 ± 27 | ||||
T-Chol (mg/dL) | 0.191* | 0.229* | 0.006* | ||||
After 3 months | 199 ± 40 | 215 ± 28 | 199 ± 22 | ||||
Baseline | 105 ± 44 | 136 ± 30 | 127 ± 31 | ||||
LDL-Chol (mg/dL) | 0.292* | 0.437* | 0.010* | ||||
After 3 months | 109 ± 45 | 132 ± 26 | 116 ± 25 | ||||
Baseline | 49 ± 17 | 53 ± 7 | 59 ± 11 | ||||
HDL-Chol (mg/dL) | 0.522* | 0.287* | 0.073* | ||||
After 3 months | 49 ± 16 | 51 ± 8 | 56 ± 15 | ||||
Baseline | 240 ± 374 | 208 ± 116 | 121 ± 55 | ||||
Triacylglycerol (mg/dL) | 0.173† | 0.136† | 0.408† | ||||
After 3 months | 289 ± 436 | 181 ± 67 | 115 ± 51 | ||||
Baseline | 113 ± 18 | 108 ± 19 | 118 ± 28 | ||||
Glucose (mg/dL) | 0.735† | 0.583† | 0.255† | ||||
After 3 months | 112 ± 21 | 107 ± 16 | 111 ± 18 | ||||
Baseline | 5.0 ± 0.3 | 5.3 ± 0.5 | 5.5 ± 0.8 | ||||
Hemoglobin A1C (%) | 0.041† | 0.033† | 0.529† | ||||
After 3 months | 5.1 ± 0.2 | 5.4 ± 0.5 | 5.5 ± 0.7 | ||||
Baseline | 3.5 ± 5.7 | 1.4 ± 2.0 | 1.9 ± 5.9 | ||||
Active ghrelin (fmol/mL) | 0.128† | 0.008† | .001† | ||||
After 3 months | 6.4 ± 7.4 | 3.8 ± 3.9 | 5.3 ± 8.4 | ||||
Baseline | 133.2 ± 161.2 | 41.6 ± 49.0 | 77.4 ± 135.4 | ||||
Desacyl ghrelin (fmol/mL) | 1.000† | 0.002† | 0.001† | ||||
After 3 months | 108.0 ± 67.7 | 101.4 ± 89.3 | 115.7 ± 180.7 | ||||
Baseline | 1692 ± 1903 | 3611 ± 2786 | 1797 ± 999 | ||||
Leptin (pg/mL) | 0.074* | 0.001* | 0.000† | ||||
After 3 months | 308 ± 219 | 610 ± 391 | 313 ± 158 |